FDA Approved: ALLOPURINOL — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Allopurinol from Actavis Pharma, Inc. (NDA018877).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia
• Urolithiasis

Drugs mentioned

• Allopurinol (Allopurinol)

Snippet

SUPPL AP for ALLOPURINOL (ALLOPURINOL)